Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer

PURPOSE: To explore the predictive value of multiple immune-inflammatory biomarkers including serum VEGFA and systemic immune-inflammation index (SII) in HER2-negative advanced gastric cancer (AGC) and establish nomograms for predicting the first-line chemotherapeutic efficacy, progression-free surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Shao, Yu, Wang, Junjun, Cheng, Qianqian, Yang, Hanqi, Li, Yulong, Liu, Jing, Zhou, Yangyang, Zhou, Zhengguang, Wang, Mingxi, Ji, Baoan, Yao, Jinghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516559/
https://www.ncbi.nlm.nih.gov/pubmed/37746295
http://dx.doi.org/10.3389/fonc.2023.1185240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516559/
https://www.ncbi.nlm.nih.gov/pubmed/37746295
http://dx.doi.org/10.3389/fonc.2023.1185240

Ejemplares similares